A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Conditions
Hypothalamic Obesity · Multiple Pituitary Hormone Deficiency Genetic Form · Septo-Optic Dysplasia · Optic Nerve Hypoplasia · Childhood-onset Combined Pituitary Hormone Deficiency · Pituitary Stalk Interruption Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama, Birmingham, Alabama, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Lurie Children's Hospital, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Children's Minnesota, Saint Paul, Minnesota, United States
Columbia University Irving Medical Center, New York, New York, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Seattle Children's Research Institute, Seattle, Washington, United States
UCL Great Ormond Street Institute of Child Health, London, Greater London, United Kingdom
Birmingham Women and Children's Hospital NHS Trust, Birmingham, West Midlands, United Kingdom
Hull Royal Infirmary, Hull, United Kingdom
Study leads
David Meeker, MD
Study Chair
Rhythm Pharmaceuticals, Inc.